1. Souka AP, Snijders RJ, Novakov A, Soares W, Nicolaides KH. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of ges-tation. Ultrasound Obstet Gynecol. 1998; 11:391–400.
Article
2. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by ma-ternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet. 1998; 352:343–346.
Article
3. Oh SY, Hong JS, Seol HJ, Hwang HS, Park HS, Kim K, Ko HS, Kwak DW, Kim MY, Park MH, Oh MJ, Park JS, Kim SJ. Korean Society of Ultrasound in Obstetrics and Gynecology Research Group. 2014 First-trimester ultrasound forum from the Korean Society of Ultrasound in Obstetrics and Gynecology. Obstet Gynecol Sci. 2015; 58:1–9.
Article
4. Sonek J, Nicolaides K. Additional first-trimester ultrasound markers. Clin Lab Med. 2010; 30:573–592.
Article
5. Kurjak A, Kupesic S, Matijevic R, Kos M, Marton U. First tri-mester malformation screening. Eur J Obstet Gynecol Reprod Biol. 1999; 85:93–96.
Article
6. Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides K. Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study. Lancet. 2001; 358:1665–1667.
Article
7. Kagan KO, Cicero S, Staboulidou I, Wright D, Nicolaides KH. Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. Ultrasound Obstet Gynecol. 2009; 33:259–264.
Article
8. Jung E, Won HS, Lee PR, Kim A. Ultrasonographic measure-ment of fetal nasal bone length in the second trimester in Ko-rean population. Prenat Diagn. 2007; 27:154–157.
Article
9. Huggon IC, DeFigueiredo DB, Allan LD. Tricuspid regurgi-tation in the diagnosis of chromosomal anomalies in the fetus at 11-14 weeks of gestation. Heart. 2003; 89:1071–1073.
Article
10. Falcon O, Faiola S, Huggon I, Allan L, Nicolaides KH. Fetal tri-cuspid regurgitation at the 11+0 to 13+6-week scan: association with chromosomal defects and reproducibility of the method. Ultrasound Obstet Gynecol. 2006; 27:609–612.
Article
11. Faiola S, Tsoi E, Huggon IC, Allan LD, Nicolaides KH. Likeli-hood ratio for trisomy 21 in fetuses with tricuspid regurgitation at the 11 to 13+6-week scan. Ultrasound Obstet Gynecol. 2005; 26:22–27.
Article
12. Maiz N, Nicolaides KH. Ductus venosus in the first trimester: contribution to screening of chromosomal, cardiac defects and monochorionic twin complications. Fetal Diagn Ther. 2010; 28:65–71.
Article
13. Donnenfeld AE, Lockwood D, Lamb AN. Prenatal diagnosis from cystic hygroma fluid: the value of fluorescence in situ hybridization. Am J Obstet Gynecol. 2001; 185:1004–1008.
Article
14. Bornstein E, Goncalves Rodríguez JL, Alvarez Pavon EC, Quiroga H, Or D, Divon MY. First-trimester sonographic find-ings associated with a Dandy-Walker malformation and inferior vermian hypoplasia. J Ultrasound Med. 2013; 32:1863–1868.
Article
15. Chaoui R, Benoit B, Mitkowska-Wozniak H, Heling KS, Nicol-aides KH. Assessment of intracranial translucency (IT) in the detection of spina bifida at the 11-13-week scan. Ultrasound Obstet Gynecol. 2009; 34:249–252.
Article
16. Lee MY, Won HS, Jeong BD, Hyun MK, Lee HY, Shim JY, Lee PR, Kim A. Measurement of intracranial translucency using three-dimensional ultrasound and Volume IT. Prenat Diagn. 2012; 32:472–475.
Article
17. Kim SK, Won HS, Shim JY, Kim KS, Lee PR, Kim A. Successful vesicoamniotic shunting of posterior urethral valves in the first trimester of pregnancy. Ultrasound Obstet Gynecol. 2005; 26:666–668.
Article
18. Salomon LJ, Alfirevic Z, Berghella V, Bilardo C, Hernandez-Andrade E, Johnsen SL, Kalache K, Leung KY, Malinger G, Munoz H, Prefumo F, Toi A, Lee W. ISUOG Clinical Standards Committee. Practice guidelines for performance of the routine mid-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol. 2011; 37:116–126.
Article
19. Song HK, Ryu HM, Roh SH, Park SH, Kim MY, Kim ES, Han HW, Choi SK, Lee YH, Yoo SJ. Prenatal diagnosis and sono-graphic findings of down syndrome: review of 30 cases. Korean J Obstet Gynecol. 1997; 40:2826–2832.
20. Vintzileos AM, Egan JF. Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography. Am J Obstet Gynecol. 1995; 172:837–844.
Article
21. Yeo L, Vintzileos AM. The second trimester genetic sonogram. In : Callen PW, editor. Ultrasonography in obstetrics and gynecology. 5th ed. London: Elsevier Health Sciences;2011. p. 70–111.
22. Nyberg DA, Kramer D, Resta RG, Kapur R, Mahony BS, Luthy DA, Hickok D. Prenatal sonographic findings of trisomy 18: review of 47 cases. J Ultrasound Med. 1993; 12:103–113.
Article
23. Cho RC, Chu P, Smith-Bindman R. Second trimester prenatal ultrasound for the detection of pregnancies at increased risk of trisomy 18 based on serum screening. Prenat Diagn. 2009; 29:129–139.
Article
24. Song MJ. Fetal sonography for the detection of chromosomal abnormality. J Korean Soc Ultrasound Med. 2011; 30:75–82.
25. Papp C, Szigeti Z, Toth-Pal E, Hajdu J, Joo JG, Papp Z. Ultra-sonographic findings of fetal aneuploidies in the second tri-mester: our experiences. Fetal Diagn Ther. 2008; 23:105–113.
Article
26. Momma K. Cardiovascular anomalies associated with chromo-some 22q11.2 deletion syndrome. Am J Cardiol. 2010; 105:1617–1624.
Article
27. Lee MY, Won HS, Baek JW, Cho JH, Shim JY, Lee PR, Kim A. Variety of prenatally diagnosed congenital heart disease in 22q11.2 deletion syndrome. Obstet Gynecol Sci. 2014; 57:11–16.
Article
28. Driscoll DA. Prenatal diagnosis of the 22q11.2 deletion syn-drome. Genet Med. 2001; 3:14–18.
Article